European Archives - Page 1105 of 1469 - European Medical Journal

Genetic Associations and Environmental Exposures in the Aetiopathogenesis of Anti-Neutrophil Cytoplasmic Antibody- Associated Vasculitis: An Updated Review

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a heterogeneous group of rare diseases characterised by necrotising…

The European Medical Journal Presents: EMJ Gastroenterology 7.1

EMJ Gastroenterology 7.1 is now available, presenting a full review of UEG Week 2018, this year held in the Austrian capital: Vienna.

Review of the 26th United European Gastroenterology Week 2018

“UEG Week provides a fantastic opportunity for clinicians and researchers to come together from all corners of the world to discuss advances in digestive…

A Worldwide Perspective on Diagnosis and Management of Diverticular Disease: Understanding Similarities and Differences

The epidemiology of diverticular disease (DD) is changing, with an increasing prevalence in younger patients from Europe and the USA, and changing disease…

Prof Sorin Barbu

Professor of Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, Romania…

EMJ Gastroenterology 7.1 2018

This eJournal marks the perfect time to catch up with the events from the United European Gastroenterology (UEG) Week 2018 in our Congress Review section…

Effects of Dietary Fibres on Indomethacin-Induced Intestinal Permeability in Elderly People: A Randomised Placebo Controlled Parallel Clinical Trial

Gastrointestinal (GI) symptoms are common among the elderly and the elevated pharmaceutical load in elderly patients is of potential harm to the intestine….

The Emerging Treatment Landscape of Inflammatory Bowel Disease: Role of Innovator Biologics and Biosimilars

Despite the fact that the treatment armamentarium for inflammatory bowel diseases (IBD) is growing, unmet medical needs remain…

Patient-Derived Organoid-Based Prediction of Concurrent Chemoradiotherapy Response in Oesophageal Cancer

Oesophageal carcinoma is the eighth most common malignancy worldwide and the seventh most common cause of death in men…

Predictive Value of PAGE-B Score in Tunisian Patients with Chronic Hepatitis B Treated with Entecavir

Current first-line oral nucleos(t)ide analogues, entecavir (ETV) and tenofovir, have had a major impact on chronic hepatitis B virus (HBV) (CHB) treatment.